Ming O. Li
Impact in
- Immunology top 0.05%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 85
- Immune Cell Function and Interaction 50
- T-cell and B-cell Immunology 39
- Immune cells in cancer 21
- Immunotherapy and Immune Responses 14
- IL-33, ST2, and ILC Pathways 11
- Immune Response and Inflammation 10
- Aging 2
- Co-authors
- Richard A. FlavellShomyseh SanjabiYisong Y. WanSoyoung OhAlexander Y. RudenskyMin PengWeiming OuyangNa Yin
- Journals
- Immunity (16 papers)The Journal of Immunology (7 papers)Nature (6 papers)Science (5 papers)The Journal of Experimental Medicine (5 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Ming O. Li
120 papers receiving 17.8k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Immunology 10.8k
- Oncology 4.6k
- Cancer Research 1.9k
- Molecular Biology 5.6k
- Immunology and Allergy 401
Countries citing papers authored by Ming O. Li
This map shows the geographic impact of Ming O. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming O. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming O. Li more than expected).
Fields of papers citing papers by Ming O. Li
This network shows the impact of papers produced by Ming O. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming O. Li. The network helps show where Ming O. Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming O. Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 31 | |
| 4 | 2023 | 77 | |
| 5 | 2023 | 39 | |
| 6 | 2022 | 17 | |
| 7 | 2022 | 59 | |
| 8 | 2022 | 55 | |
| 9 | Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity Hit paper breakdown → | 2021 | 252 |
| 10 | 2021 | 2 | |
| 11 | 2021 | 33 | |
| 12 | 2020 | 111 | |
| 13 | 2019 | 156 | |
| 14 | 2018 | 147 | |
| 15 | 2017 | 66 | |
| 16 | Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism Hit paper breakdown → | 2016 | 599 |
| 17 | 2013 | 179 | |
| 18 | 2005 | 31 | |
| 19 | 2004 | 337 | |
| 20 | KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma Hit paper breakdown → | 1996 | 636 |
About Ming O. Li
Ming O. Li is a scholar working on Immunology, Aging, Cancer Research, Oncology and Molecular Biology, having authored 124 papers that have together received 18.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (50 papers), T-cell and B-cell Immunology (39 papers), Immune cells in cancer (21 papers), Immunotherapy and Immune Responses (14 papers), IL-33, ST2, and ILC Pathways (11 papers), FOXO transcription factor regulation (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Response and Inflammation (10 papers). The work is most often cited by research in Immunology (10.8k citations), Oncology (4.6k citations), Cancer Research (1.9k citations), Molecular Biology (5.6k citations) and Immunology and Allergy (401 citations). Ming O. Li has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Richard A. Flavell, Shomyseh Sanjabi, Yisong Y. Wan, Soyoung Oh, Alexander Y. Rudensky, Min Peng, Weiming Ouyang, Na Yin, Ruth A. Franklin and Will Liao. Their work appears in journals such as Immunity, The Journal of Immunology, Nature, Science and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.